These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11071847)
1. Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells. Junicho A; Matsuda T; Yamamoto T; Kishi H; Korkmaz K; Saatcioglu F; Fuse H; Muraguchi A Biochem Biophys Res Commun; 2000 Nov; 278(1):9-13. PubMed ID: 11071847 [TBL] [Abstract][Full Text] [Related]
2. Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells. Matsuda T; Junicho A; Yamamoto T; Kishi H; Korkmaz K; Saatcioglu F; Fuse H; Muraguchi A Biochem Biophys Res Commun; 2001 Apr; 283(1):179-87. PubMed ID: 11322786 [TBL] [Abstract][Full Text] [Related]
3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
4. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Gross M; Liu B; Tan J; French FS; Carey M; Shuai K Oncogene; 2001 Jun; 20(29):3880-7. PubMed ID: 11439351 [TBL] [Abstract][Full Text] [Related]
5. Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1. Zhang Y; Fondell JD; Wang Q; Xia X; Cheng A; Lu ML; Hamburger AW Oncogene; 2002 Aug; 21(36):5609-18. PubMed ID: 12165860 [TBL] [Abstract][Full Text] [Related]
6. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of the androgen receptor by bombesin and low-dose androgen. Dai J; Shen R; Sumitomo M; Stahl R; Navarro D; Gershengorn MC; Nanus DM Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445 [TBL] [Abstract][Full Text] [Related]
11. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. Rödel B; Tavassoli K; Karsunky H; Schmidt T; Bachmann M; Schaper F; Heinrich P; Shuai K; Elsässer HP; Möröy T EMBO J; 2000 Nov; 19(21):5845-55. PubMed ID: 11060035 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Chen T; Wang LH; Farrar WL Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674 [TBL] [Abstract][Full Text] [Related]
13. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
14. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
16. Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice. DeMiguel F; Lee SO; Lou W; Xiao X; Pflug BR; Nelson JB; Gao AC Prostate; 2002 Jul; 52(2):123-9. PubMed ID: 12111703 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells. Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel HG Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Ni Z; Lou W; Leman ES; Gao AC Cancer Res; 2000 Mar; 60(5):1225-8. PubMed ID: 10728680 [TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]